Spatiotemporal evolution of the ccRCC microenvironment links intra-tumoral heterogeneity to immune escape
Mahdi Golkaram(Illumina (United States)), A. Ari Hakimi(Penn State Milton S. Hershey Medical Center), Vlad Makarov(Memorial Sloan Kettering Cancer Center), Victor E. Reuter(Memorial Sloan Kettering Cancer Center), Phillip M. Rappold(Unknown), Raakhee Vijayaraghavan(Illumina (United States)), Ritesh R. Kotecha(Memorial Sloan Kettering Cancer Center), Paul Russo(Memorial Sloan Kettering Cancer Center), Jeremy C. Durack(Memorial Sloan Kettering Cancer Center), Renzo G. DiNatale(Memorial Sloan Kettering Cancer Center), Traci Pawlowski(Illumina (United States)), Michael Salmans(Illumina (United States)), Sounak Gupta(Mayo Clinic), Jim Godsey(Illumina (United States)), Shile Zhang(Guardant (United States)), Kyle A. Blum(Memorial Sloan Kettering Cancer Center), Robert J. Motzer(Memorial Sloan Kettering Cancer Center), Maria I. Carlo(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Cleveland Clinic), Jonathan Coleman(Memorial Sloan Kettering Cancer Center), Ed Reznik(Icahn School of Medicine at Mount Sinai), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), Rami Mehio(Illumina (United States)), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Cerise Tang(Yara (Norway)), Chen Zhao(Illumina (United States)), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), Li Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengshen Kuo(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k